Can We Finally Reverse Knee Arthritis? Stem Cells, Cartilage, and a Little Cautious Optimism

A Great Friend, a New Discovery, and the Possibility of Rebuilding Arthritic Knees

One of my great friends—a thoughtful, wise individual whose friendship and curiosity I value enormously—recently sent me a fascinating article from MedPage Today about an experimental cell therapy for knee osteoarthritis.

One of the wonderful things about having good friends is that they occasionally send you something that makes you stop, think, and reconsider what you thought you knew.

This article certainly did that.

After decades of orthopedic surgery, I have seen extraordinary advances in joint replacement, surgical techniques, and rehabilitation. But one challenge has remained stubbornly difficult: reliably restoring cartilage that has been lost to arthritis.

Now researchers are investigating a treatment that may eventually help us do something more than relieve symptoms.

Could we actually repair damaged cartilage and alter the course of knee osteoarthritis?

That's a remarkable possibility, although the evidence is still preliminary.

My friend's article reminded me that medical progress often begins with someone asking whether yesterday's impossible might become tomorrow's routine.

And, of course, it also reminded me that having wise friends is considerably less expensive than hiring a team of medical researchers.

Today's Second Musing: "Can We Finally Reverse Knee Arthritis? Stem Cells, Cartilage, and a Little Cautious Optimism."

If this treatment eventually works as hoped, perhaps we'll all be playing pickleball well into our nineties.

Although I'm not sure it will do anything about questionable line calls.

— Dr. Pickleball

What Is This New Treatment?

Researchers are investigating a combination treatment called OSCA, which brings together two components:

• Mesenchymal stromal cells derived from donated umbilical cord blood.
• A cartilage-derived acellular matrix intended to provide a supportive environment for tissue repair.

The treatment is administered through an injection into the knee joint.

The idea is to influence the biological processes involved in osteoarthritis and potentially improve the joint's structure—not merely reduce pain.

That distinction is important.

Most treatments available today help patients manage the consequences of arthritis. A genuine disease-modifying therapy could potentially change how the disease progresses.

What Did the Early Research Show?

The treatment has been investigated in early clinical studies, including a randomized, placebo-controlled phase 2a trial involving 113 patients with knee osteoarthritis.

Researchers evaluated pain, function, MRI findings, biomarkers, and safety.

The reported findings were encouraging enough to justify further investigation, including the possibility of favorable changes in joint structure.

But there are several important qualifications.

An improvement on an MRI does not necessarily mean that normal, durable articular cartilage has been restored.

Nor does it establish that a patient will avoid knee replacement ten or twenty years later.

We need larger trials, longer follow-up, and independent confirmation before declaring that osteoarthritis has been reversed.

That is particularly important when evaluating a treatment likely to be expensive.

Why This Could Be a Major Orthopedic Advance

For much of my orthopedic career, treating knee arthritis involved a progression of options.

We began with exercise modification, strengthening, physical therapy, weight management, and medications.

When appropriate, we used injections or braces.

And when the joint became sufficiently painful and dysfunctional, we considered knee replacement.

These approaches can be very effective, particularly when matched to the individual patient's symptoms and needs.

But none has consistently demonstrated the ability to regenerate normal cartilage throughout an arthritic knee.

A treatment that could reliably slow, halt, or reverse structural deterioration would change the way we approach osteoarthritis.

Imagine a patient in their fifties with early knee arthritis who could preserve their natural joint for decades.

That would be far more meaningful than simply improving a laboratory marker or producing a prettier MRI.

What About the Cost?

The original article suggests that this approach may not be inexpensive.

That would not be surprising.

Manufacturing, testing, processing, storing, and administering cell-based therapies can be complicated and costly.

But we do not yet have an established commercial price or reliable evidence of long-term cost-effectiveness for this investigational treatment.

If future studies demonstrate that it meaningfully delays or prevents knee replacement, the economics could become quite interesting.

Until then, a high price tag should not be confused with proven effectiveness.

After all, a Lamborghini costs considerably more than a Toyota, but neither one has been shown to regenerate knee cartilage.

What Should Pickleball Players Do Right Now?

While we wait for better evidence, there are several well-established ways to improve knee function and manage arthritis.

1. Preserve your muscle mass.

Strong quadriceps, hamstrings, and hip muscles help support the knee. Resistance training becomes increasingly important as we age.

2. Maintain a healthy weight.

Excess body weight increases the mechanical demands placed on the knee. Even modest weight reduction can improve symptoms in many patients.

3. Keep moving.

Arthritis does not automatically mean you should stop exercising. Low-impact conditioning, strengthening, and appropriate modifications can help preserve mobility.

Pickleball may remain possible, although some players need to adjust their playing frequency, intensity, or movement patterns.

4. Consider physical therapy and appropriate bracing.

Targeted strengthening, movement training, and selected unloading braces may improve comfort and function.

5. Know when surgery makes sense.

For advanced arthritis with substantial pain and functional limitation despite appropriate nonsurgical treatment, knee replacement remains a well-established and effective option.

No experimental injection should be assumed to replace a properly indicated knee replacement.